Valuation: Shandong Pharmaceutical Glass Co.Ltd

Capitalization 16.23B 2.23B 2.15B 2.02B 1.8B 3.19B 195B 3.55B 24.34B 9.04B 80.09B 8.35B 8.18B 337B P/E ratio 2024 *
16.6x
P/E ratio 2025 * 13.9x
Enterprise value 13.13B 1.8B 1.74B 1.64B 1.45B 2.58B 158B 2.88B 19.69B 7.32B 64.81B 6.75B 6.62B 272B EV / Sales 2024 *
2.4x
EV / Sales 2025 * 2.02x
Free-Float
79.37%
Yield 2024 *
1.61%
Yield 2025 * 2.15%
More valuation ratios * Estimated data
Dynamic Chart
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2024 24-10-28 CI
Shandong Pharmaceutical Glass' H1 Profit Jumps 23%, Operating Income Up 7%; Shares Soar 10% 24-08-27 MT
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2024 24-08-26 CI
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 24-04-22 CI
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 23-10-18 CI
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 23-08-28 CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 23-04-24 CI
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 23-04-24 CI
Shandong Pharmaceutical Glass Co., Ltd announced that it has received CNY 1.866494692 billion in funding 22-11-28 CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 22-10-28 CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 22-08-29 CI
Triumph Science & Technology Co.,Ltd cancelled the acquisition of a 11% stake in Shandong Pharmaceutical Glass Co., Ltd from Shandong Luzhong Investment Co., Ltd. 22-07-19 CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 22-04-25 CI
More news
1 day+1.83%
1 week+1.49%
Current month+1.49%
1 month-0.61%
3 months-5.27%
6 months+0.82%
Current year-5.12%
More quotes
1 week
23.56
Extreme 23.56
24.55
1 month
23.27
Extreme 23.27
25.03
Current year
23.27
Extreme 23.27
27.25
1 year
21.64
Extreme 21.64
32.33
3 years
18.63
Extreme 18.63
33.68
5 years
18.63
Extreme 18.63
76.85
10 years
5.28
Extreme 5.2806
76.85
More quotes
Director TitleAgeSince
Chief Executive Officer 55 2020-01-06
Director of Finance/CFO 51 2013-05-10
Corporate Officer/Principal 53 2013-05-10
Manager TitleAgeSince
Chairman 70 2019-05-12
Director/Board Member 55 2013-05-10
Director/Board Member 48 2013-05-10
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+1.83%+1.49%-9.58%-27.96% 2.19B
-2.86%-4.43%-14.93%+4.32% 3.58B
-0.31%-2.02%+6.09%+51.74% 3.37B
-0.52%-3.77%-29.90%-15.27% 1.79B
-0.82%-7.90%-28.26%-31.22% 894M
-1.20%-2.95%-29.57%-54.35% 547M
-0.49%+2.73%+27.32%-21.39% 510M
+1.66%-0.90%+36.97%+16.21% 485M
+1.94%+2.63%+45.03%-44.86% 341M
Average -0.09%-1.01%+0.35%-13.64% 1.52B
Weighted average by Cap. -0.61%-2.15%-7.41%+1.87%
See all sector performances

Financials

2024 *2025 *
Net sales 5.46B 749M 725M 681M 604M 1.07B 65.72B 1.2B 8.19B 3.04B 26.96B 2.81B 2.75B 113B 6.19B 850M 822M 773M 685M 1.22B 74.52B 1.36B 9.29B 3.45B 30.57B 3.19B 3.12B 128B
Net income 968M 133M 128M 121M 107M 190M 11.65B 212M 1.45B 540M 4.78B 498M 488M 20.09B 1.17B 160M 155M 145M 129M 229M 14.03B 255M 1.75B 650M 5.76B 600M 588M 24.19B
Net Debt -3.1B -425M -411M -386M -343M -608M -37.26B -678M -4.65B -1.73B -15.29B -1.59B -1.56B -64.24B -3.69B -506M -489M -460M -408M -724M -44.34B -807M -5.53B -2.05B -18.19B -1.9B -1.86B -76.45B
More financial data * Estimated data
Logo Shandong Pharmaceutical Glass Co.Ltd
Shandong Pharmaceutical Glass Co Ltd is a China-based company mainly engaged in the research and development, production and sales of various pharmaceutical glass bottle products. The Company operates five segments, including Packaging Products segment, Trading segment, Barreled Water segment, Logistics segment, and Service segment. The Company’s main glass bottle products include molded bottle series products, brown bottle series products, ampoules, and tube bottles. The Company’s products also include butyl rubber plug products, aluminum-plastic caps, plastic bottle products, and others. The Company's products are widely used in the packaging of various products such as medicines, health products, and cosmetics. The Company mainly conducts businesses within the domestic market.
Employees
-
Calendar
More about the company
Date Price Change Volume
25-02-07 24.45 ¥ +1.83% 12,522,200
25-02-06 24.01 ¥ +0.88% 10,655,050

End-of-day quote Shanghai S.E., February 06, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
24.45CNY
Average target price
31.53CNY
Spread / Average Target
+28.95%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600529 Stock